Rafarma Pharmaceutical news update
30 nov. 2023 09h30 HE
|
Rafarma Pharmaceuticals Inc.
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet...
Developing New Treatments for Mania Using Brain-Based Risk Markers - A Free Webinar from the Brain & Behavior Research Foundation
04 nov. 2021 08h59 HE
|
Brain & Behavior Research Foundation
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Mania Using Brain-Based Risk Markers” on...
IMAC Holdings Announces Closing of its Public Offering of Common Stock for Total Gross Proceeds of $17.0 Million
26 mars 2021 11h18 HE
|
IMAC Holdings, Inc.
Brentwood, Tenn., March 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in...